Kiromic Biopharma, Inc. Operating Lease Cost
Kiromic Biopharma, Inc. reported Operating Lease Cost of $179.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-10
- Kiromic Biopharma, Inc. operating lease, cost for the quarter ending 2024-03-31 was $179.00K, a 0.56% decline year-over-year.
- Kiromic Biopharma, Inc. operating lease, cost for the quarter ending 2023-12-31 was $179.10K, a 4.43% increase year-over-year.
- Kiromic Biopharma, Inc. operating lease, cost for the quarter ending 2023-09-30 was $179.00K, a 4.31% increase year-over-year.
- Kiromic Biopharma, Inc. operating lease, cost for the quarter ending 2023-06-30 was $179.00K, a 5.60% increase year-over-year.
- Kiromic Biopharma, Inc. operating lease, cost for fiscal 2023 was $716.10K, a 7.99% increase from fiscal 2022.
- Kiromic Biopharma, Inc. operating lease, cost for fiscal 2022 was $663.10K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $179.00K 10-Q · filed 2024-05-10 | $358.10K derived: sum of 2 quarters · filed 2024-05-10 | $537.10K derived: sum of 3 quarters · filed 2024-05-10 | $716.10K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2023-12-31 | $179.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $358.10K derived: sum of 2 quarters · filed 2024-03-19 | $537.10K derived: sum of 3 quarters · filed 2024-03-19 | $716.10K 10-K · filed 2024-03-19 | |
| 2023-09-30 | $179.00K 10-Q · filed 2023-11-14 | $358.00K derived: sum of 2 quarters · filed 2023-11-14 | $537.00K 10-Q · filed 2023-11-14 | $709.50K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2023-06-30 | $179.00K 10-Q · filed 2023-08-14 | $358.00K 10-Q · filed 2023-08-14 | $530.50K derived: sum of 3 quarters · filed 2024-05-10 | $702.10K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2023-03-31 | $180.00K 10-Q · filed 2024-05-10 | $179.00K 10-Q · filed 2023-05-15 | $351.50K derived: sum of 2 quarters · filed 2024-05-10 | $523.10K derived: sum of 3 quarters · filed 2024-05-10 | $692.60K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $171.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $343.10K derived: sum of 2 quarters · filed 2024-03-19 | $512.60K derived: sum of 3 quarters · filed 2024-03-19 | $663.10K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $171.60K 10-Q · filed 2023-11-14 | $341.10K derived: sum of 2 quarters · filed 2023-11-14 | $491.60K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $169.50K 10-Q · filed 2023-08-14 | $320.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $150.40K 10-Q · filed 2023-05-15 |